Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States

被引:301
作者
An, Kit Sing
Williams, Aimee T.
Roach, E. Steve
Batchelor, Lori
Sparagana, Steven P.
Delgado, Mauricio R.
Wheless, James W.
Baumgartner, James E.
Roa, Benjamin B.
Wilson, Carolyn M.
Smith-Knuppel, Teresa K.
Cheung, Min-Yuen C.
Whittemore, Vicky H.
King, Terri M.
Northrup, Hope
机构
[1] Univ Texas, Sch Med, Dept Pediat, Houston, TX 77030 USA
[2] Univ Texas, Sch Med, Dept Neurol, Houston, TX 77030 USA
[3] Univ Texas, Sch Med, Dept Surg, Houston, TX 77030 USA
[4] Texas Scottish Rite Hosp Children, Dallas, TX USA
[5] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[6] TB Sclerosis Alliance, Silver Spring, MD USA
关键词
tuberous sclerosis complex; tumor suppressor gene; mutation screening; genotype-phenotype correlation; meta-analysis;
D O I
10.1097/GIM.0b013e31803068c7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Tuberous sclerosis complex is an autosomal dominant neurocutaneous disorder marked by hamartoma growth in multiple organ systems. We performed mutational analyses on 325 individuals with definite tuberous sclerosis complex diagnostic status. We identified mutations in 72% (199/257) of de novo and 77% (53/68) of familial cases, with 17% of mutations in the TSCI gene and 50% in the TSC2gene. There were 4% unclassified variants and 29% with no mutation identified. Genotype/phenotype analyses of all observed tuberous sclerosis complex findings in probands were performed, including several clinical features not analyzed in two previous large studies. We showed that patients with TSC2 mutations have significantly more hypomelanotic macules and learning disability in contrast to those with TSC1 mutations, findings not noted in previous studies. We also observed results consistent with two similar studies suggesting that individuals with mutations in TSC2 have more severe symptoms. On performing meta-analyses of our data and the other two largest studies in the literature, we found significant correlations for several features that individual studies did not have sufficient power to conclude. Male patients showed more frequent neurologic and eye symptoms, renal cysts, and ungual fibromas. Correlating genotypes with phenotypes should facilitate the disease management of tuberous sclerosis complex.
引用
收藏
页码:88 / 100
页数:13
相关论文
共 38 条
[1]   Molecular genetic basis of tuberous sclerosis complex: From bench to bedside [J].
An, KS ;
Williams, AT ;
Gambello, MJ ;
Northrup, H .
JOURNAL OF CHILD NEUROLOGY, 2004, 19 (09) :699-709
[2]   Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients [J].
Au, KS ;
Rodriguez, JA ;
Finch, JL ;
Volcik, KA ;
Roach, ES ;
Delgado, MR ;
Rodriguez, E ;
Northrup, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (02) :286-294
[3]  
Au KS, 1997, HUM MUTAT, V9, P23, DOI 10.1002/(SICI)1098-1004(1997)9:1<23::AID-HUMU4>3.3.CO
[4]  
2-8
[5]   Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs [J].
Dabora, SL ;
Jozwiak, S ;
Franz, DN ;
Roberts, PS ;
Nieto, A ;
Chung, J ;
Choy, YS ;
Reeve, MP ;
Thiele, E ;
Egelhoff, JC ;
Kasprzyk-Obara, J ;
Domanska-Pakiela, D ;
Kwiatkowski, DJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (01) :64-80
[6]   Evolution of cardiac rhabdomyoma in tuberous sclerosis complex [J].
DiMario, FJ ;
Diana, D ;
Leopold, H ;
Chameides, L .
CLINICAL PEDIATRICS, 1996, 35 (12) :615-619
[7]  
GOULD SR, 1991, ANN NY ACAD SCI, V615, P71
[8]   Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis [J].
Jones, AC ;
Daniells, CE ;
Snell, RG ;
Tachataki, M ;
Idziaszczyk, SA ;
Krawczak, M ;
Sampson, JR ;
Cheadle, JP .
HUMAN MOLECULAR GENETICS, 1997, 6 (12) :2155-2161
[9]   Comprehensive mutation analysis of TSC1 and TSC2 -: and phenotypic correlations in 150 families with tuberous sclerosis [J].
Jones, AC ;
Shyamsundar, MM ;
Thomas, MW ;
Maynard, J ;
Idziaszczyk, S ;
Tomkins, S ;
Sampson, JR ;
Cheadle, JP .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (05) :1305-1315
[10]   Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway [J].
Jozwiak, J ;
Jozwiak, S ;
Grzela, T ;
Lazarczyk, M .
NEUROMOLECULAR MEDICINE, 2005, 7 (04) :287-296